It is possible that the highly specific heparin-binding domains of VEGF limits loading due to the specific orientation and presentation of binding sites presented by heparin.
All sites presented in Table 1 participated in this experiment.
However, only 45.9% of designated implant sites presented sinus mucosal thickening.
The seasonality of APP, at both sites, presented a similarity in the general tendencies.
All sites presented in Table 1 except for the first one, participated in this experiment.
Coastal sites presented significantly lower TN (Mann–Whitney U test; p < 0.05).
The nature of the active sites presented in the ZN catalyst influences the polyethylene properties.
It could be construed from the GC analysis that polar solvent can cover the reactive sites presented on the surface of ZnO NPs, including Bronsted and Lewis sites.
Furthermore, all grafted sites presented, when healing was completed, an optimal integration with the surrounding tissues, as stated by other authors in previous studies [15 17].
